These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. Tammali R; Saxena A; Srivastava SK; Ramana KV J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240 [TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Saxena A; Shoeb M; Tammali R; Ramana KV; Srivastava SK Cancer Lett; 2014 Dec; 355(1):141-7. PubMed ID: 25218594 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells. Ramana KV; Tammali R; Srivastava SK Mol Cancer Ther; 2010 Apr; 9(4):813-24. PubMed ID: 20354121 [TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. Sonowal H; Pal PB; Wen JJ; Awasthi S; Ramana KV; Srivastava SK Sci Rep; 2017 Jun; 7(1):3182. PubMed ID: 28600556 [TBL] [Abstract][Full Text] [Related]
9. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc Saxena A; Tammali R; Ramana KV; Srivastava SK Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349 [TBL] [Abstract][Full Text] [Related]
14. Aldose Reductase Inhibitor Fidarestat as a Promising Drug Targeting Autophagy in Colorectal Carcinoma: a Pilot Study. Pandey S Asian Pac J Cancer Prev; 2015; 16(12):4981-5. PubMed ID: 26163626 [TBL] [Abstract][Full Text] [Related]
15. [Ginsenoside Re regulates mitochondrial biogenesis through Nrf2/HO-1/PGC-1α pathway to reduce hypoxia/reoxygenation injury in H9c2 cells]. Xin GJ; Chen YY; Liu ZX; Xu SJ; Zhang HY; Guo F; Peng H; Li L; Han X; Liu JX; Fu JH Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1064-1072. PubMed ID: 38621913 [TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis. Joe Y; Zheng M; Kim HJ; Uddin MJ; Kim SK; Chen Y; Park J; Cho GJ; Ryter SW; Chung HT Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G21-9. PubMed ID: 25951827 [TBL] [Abstract][Full Text] [Related]
17. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629 [TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a. Saxena A; Tammali R; Ramana KV; Srivastava SK Antioxid Redox Signal; 2013 Apr; 18(11):1249-62. PubMed ID: 22978663 [TBL] [Abstract][Full Text] [Related]
19. Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. MacGarvey NC; Suliman HB; Bartz RR; Fu P; Withers CM; Welty-Wolf KE; Piantadosi CA Am J Respir Crit Care Med; 2012 Apr; 185(8):851-61. PubMed ID: 22312014 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer. Jang HJ; Hong EM; Kim M; Kim JH; Jang J; Park SW; Byun HW; Koh DH; Choi MH; Kae SH; Lee J Oncotarget; 2016 Jul; 7(29):46219-46229. PubMed ID: 27323826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]